Letter to the Editor: Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis: Contrast-Enhanced Ultrasound May Be a Choice.

Li, Jiangfa; Wang, Jiming; Yu, Shuiping; Yuan, Guandou; He, Songqing

Li, Jiangfa; Wang, Jiming; Yu, Shuiping; Yuan, Guandou; He, Songqing.

Afiliação

Li J; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Wang J; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yu S; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yuan G; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
He S; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Hepatology ; 71(1): 392, 2020 01.

Article em En | MEDLINE | ID: mdl-31222762

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Análise Custo-Benefício; Humanos; Cirrose Hepática; Imageamento por Ressonância Magnética; Ultrassonografia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google